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A B S T R A C T
Asplenic patients are at increased risk for sepsis and fulminant infection. Sepsis in these patients is
typically secondary to encapsulated bacteria, with Streptococcus pneumoniae being the most frequent
pathogen. Rare complications of severe sepsis include purpura fulminans and bilateral adrenal
hemorrhage (Waterhouse-Friderichsen syndrome).
We present the case of a 36-year-old woman, healthy except for splenectomy years prior for idiopathic
thrombocytopenic purpura treatment, who presented with fever. Upon presentation to our hospital,
three hours after symptoms onset, she had purpura fulminans and shock. Despite timely antimicrobials
and maximal resuscitative efforts, her disease progressed and she expired 12 hours after symptoms
onset. Autopsy revealed bilateral adrenal hemorrhage; acute adrenal crisis likely contributed to her
refractory shock. Prior to her presentation, she had not received guideline-based post-splenectomy care.
Sepsis in asplenic patients can be fulminant and rapidly fatal. Streptococcus pneumoniae remains the
most frequent cause, despite decreasing rates in recent years related to widespread pneumococcal
vaccination. Guideline-based vaccinations and “pill-in-pocket” therapy can be life-saving for asplenic
patients. Purpura fulminans represents an extreme manifestation of disseminated intravascular
coagulation, is more common in asplenic patients, and portends a poor prognosis. Waterhouse-
Friderichsen syndrome can be seen concurrently with purpura fulminans and further portends a poor
prognosis; pre-mortem diagnosis requires a high index of suspicion.
ã 2016 The Authors. Published by Elsevier Ltd. This is an open access article under the CC BY-NC-ND
license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
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Asplenic hosts are at increased risk of sepsis, which can be
fulminant and rapidly progressive, with mortality rates estimated
at 50% [1]. Streptococcus pneumoniae is the most common cause of
sepsis in asplenic patients [2]. Although rates of pneumococcal
sepsis have been decreasing since the widespread use of
pneumococcal vaccines [3], overall rates of guideline-based
post-splenectomy vaccinations and care remain low [4].* Corresponding author at: Andrew Hale. Lowry Medical Ofﬁce Building,
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2214-2509/ã 2016 The Authors. Published by Elsevier Ltd. This is an open access article unPurpura fulminans and Waterhouse-Friderichsen syndrome are
rare, life-threatening complications of sepsis. Purpura fulminans
represents severe disseminated intravascular coagulation with
hemorrhagic skin necrosis. The classic presentation is diffuse,
retiform purpura or angular purpuric lesions [5]. Waterhouse-
Friderichsen syndrome was ﬁrst described in 1911 as adrenal
hemorrhage and subsequent adrenal crisis related to sepsis [6]. It is
often accompanied by disseminated intravascular coagulation and
purpura fulminans and also carries a poor prognosis. Treatment
consists of stress-dose steroids and treatment of the underlying
infection.
We report here a case of a young, asplenic but otherwise healthy
woman who presented with fulminant sepsis, purpura fulminans,
and Waterhouse-Friderichsen from Streptococcus pneumoniae
blood stream infection. She had not received appropriate post-
splenectomy interventions.der the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
Fig. 1. Peripheral blood smear obtained upon presentation to the Emergency
Department. Two pairs of diplococci are seen (red circle) phagocytosed within a
macrophage. Pneumococcal antigen testing (antigen latex agglutination test) was
then done and returned positive, while meningococcal antigen testing was
negative.
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A 36-year-old woman with a history of idiopathic thrombocy-
topenic purpura status post splenectomy presented with sudden
onset of nausea, vomiting, diarrhea, and abdominal pain. Seven
hours before presentation, she went to sleep in her usual state of
health. Three hours before presentation, she awoke with sudden
onset of low-grade fever, nausea, vomiting, diarrhea, abdominal
pain, and worsening pain in all of her extremities. She then
presented to our hospital with an evolving dark, purpuric rash on
face and extremities. Her medications included lamotrigine and
trazadone. She had an allergy to sulfonamide medications. She had
two sons, 8 and 10 years old, worked at a daycare facility and lived
in a wooded area in Massachusetts. One month previously, she had
traveled to Martha’s Vineyard. She owned a dog, and did not
smoke, drink alcohol, or use recreational drugs.
Upon initial physical examination, she appeared ill and in
extremis. The bloodpressurewas 105/60 mmHg, pulsewas 133 beats
per minute, temperature 99.5F (37.5C), respirations 36 breaths per
minute, and oxygen saturation 94% on room air. Examination was
notable for rigors, tachycardia, tachypnea, diffusely tender extremi-
ties, and a purpuric rash on the face, tongue, palate, all four
extremities, abdomen, and back. Physical examination was other-
wise normal. Laboratory analysis was notable for white blood cell
count 6.9  103/uL (reference range 4.0-11.0  103/uL) with 9% band
forms, hemoglobin 10 g/dL (14.0-18.0 g/dL), and platelets 15 103/uL
(150–450  103/uL). Serum bicarbonate was 8mEq/L (22–28 mEq/L)
and serum creatinine was 3.3 mg/dL (0.5-1.2 mg/dL). Serum lactate
was 8.7 mmol/L (0.5-2.0 mmol/L). ALT was 81 IU/L (0–40 IU/L), AST
was 350 IU/L (0–40 IU/L), total bilirubin was 1.3 mg/dL (0.1-1.5 mg/
dL) and alkaline phosphatase was 50 IU/L (39–117 IU/L). Interna-
tional Normalized Ratio (INR) was 5.0 (0.9-1.1) and prothrombin
time was 49.6 s (22–35 s). A random cortisol level was 2.5ug/dL (5–
20ug/dL). Initial chest X-ray showed no abnormalities, although a
subsequentone several hours latershowedpuffy, bilateral inﬁltrates.
She developed progressive respiratory failure and was intu-
bated. Subsequently, she developed progressive hypotension
refractory to intravenous ﬂuid boluses and was thus started on
multiple vasopressors. The initial differential diagnosis included
encapsulated organisms such as meningococcus and pneumococ-
cus, Staphylococcus aureus,Capnocytophaga, Streptococcus pyogenes,
and tick-borne pathogens including babesiosis. She was started
promptly on empiric vancomycin, ceftriaxone, quinine, clindamy-
cin, and doxycycline. She was given platelets, cryoprecipitate, and
fresh frozen plasma for disseminated intravascular coagulation,
and stress-dose steroids. Eight hours after presentation, the
patient developed shock refractory to four vasopressors and
intravenous ﬂuids, her purpuric rash had signiﬁcantly extended,
and a bedside echocardiogram showed minimally functional
myocardium. She suffered cardiac arrest soon thereafter and
expired. An attempt was made to give her protein C concentrate,
but this did not arrive before her death.
Blood cultures drawn in the Intensive Care Unit, post
antimicrobial administration, were negative. No blood cultures
prior to antimicrobial administration were processed. Serial blood
smears were negative for intracellular organisms. Posthumously,
on a blood smear used to rule-out babesiosis, we identiﬁed
macrophages that had phagocytosed diplococci. Since the Wright
stain stains all bacteria blue, it was unclear if these diplococci were
Gram-positive or Gram-negative (Fig. 1). Pneumococcal antigen
testing (antigen latex agglutination test) was then done and
returned positive, while meningococcal antigen testing was
negative, conﬁrming the diagnosis of Streptococcus pneumoniae
infection.
An autopsy was performed. Evidence of diffuse intravascular
coagulation was found. Pulmonary examination was consistentwith Acute Respiratory Distress Syndrome. Renal microscopic
examination revealed extensive microvascular thrombotic disease.
Bilateral adrenal glands showed evidence of extensive hemor-
rhage, consistent with the Waterhouse-Friderichsen syndrome
(Fig. 2). Skin histology was consistent with diffuse disseminated
intravascular coagulation (DIC) and purpura fulminans (Fig. 3).
Discussion
Sepsis in the asplenic host can be fulminant and rapidly
progressive, with mortality rates approaching 50% [1,2]. Our case
describes a previously healthy young woman, status-post splenec-
tomy 15 years prior, who presented to our hospital after only a few
hours of symptoms, and then rapidly declined, resulting in death
within 12 hours of symptoms onset. She had evidence of extensive
disseminated intravascular coagulation and purpura fulminans
upon presentation. The major differential for infectious causes of
purpura fulminans in the asplenic patient is Neisseria meningitidis,
Capnocytophaga, Streptococcus pneumoniae, Streptococcus pyo-
genes, Staphylococcus aureus, and Haemophilus inﬂuenzae; it is
noteworthy to point out that babesiosis can present in a fulminant
fashion in asplenic hosts [7], thus given our patient had recently
been on Martha’s Vineyard and lived in an Ixodes scapularis tick
endemic area, we empirically started empiric babesia therapy with
quinine and clindamycin. Additionally, because she owned a dog,
there was initial concern for a Capnocytophaga infection, which has
been shown to cause fulminant infection in asplenic patients as
well [8]. In the end, she was found to have evidence of
pneumococcal sepsis.
Pneumococcal infection is the most common cause of fulminant
infection in the asplenic host [2]. Data from the 19900s suggested a
3.2% incidence of sepsis after splenectomy over 6.9 years of follow-
up [9], though rates have dropped since universal institution of the
7-valent pneumococcal conjugate vaccine (PCV7) in 2000 for
young children, replaced by 13-valent pneumococcal conjugate
vaccine (PCV13) in 2010 [3]. Some authors have advocated asplenic
patients have a “pill-in-pocket”, referring to an anti-pneumococcal
oral antimicrobial rapidly available to take at home at ﬁrst onset of
fever [2]. In our patient’s case, she had not received appropriate
post-splenectomy vaccinations, and she did not have any
antimicrobials available at home. Given the severity of her
condition upon presentation to medical attention, these likely
Fig. 3. Biopsy of the skin taken at autopsy shows evidence of diffuse intravascular
coagulation (DIC) and microthrombi within peripheral vessels (black arrow),
consistent with purpura fulminans.
Fig. 2. Bilateral adrenal glands were found on autopsy to have diffuse intra-parenchymal hemorrhage (dark brown areas), consistent with the Waterhouse-Friderichsen
syndrome.
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outcome.
Post-mortem, she was found to have bilateral adrenal hemor-
rhage, consistent with the Waterhouse-Friderichsen syndrome.
Given her random cortisol level was 2.5ug/dL, she was treated with
stress-dose steroids, but adrenal crisis may have contributed to her
fulminant course. A cortisol level greater than 20 ug/dL excludes
the diagnosis, while a cortisol level <5 ug/dL during a state of shock
supports the diagnosis [10]. Waterhouse-Friderichsen syndrome is
typically caused by Neisseria meningitidis, but has been reported in
sepsis from Streptococcus pneumoniae, Neisseria gonorrhoeae,
Pseudomonas aeruginosa, Escherichia coli, Haemophilus inﬂuenzae,
and Staphylococcus aureus [11]. Waterhouse-Friderichsen syn-
drome is seen most frequently in patients with asplenia, and cases
have even been reported in asplenic patients who received the
appropriate vaccines. Treatment is with corticosteroids and
appropriate antimicrobials. Waterhouse-Friderichsen syndrome
typically presents in patients who additionally have abdominal or
ﬂank pain and disseminated intravascular coagulopathy with
associated purpura fulminans [12], as was seen in our patient.
The role of therapeutic protein C in the management of patients
with purpura fulminans is a matter of controversy. The 2001 large,
randomized-controlled PROWESS trial [13] suggested that giving
activated protein C (tradename Xigris) to patients with sepsis
signiﬁcantly improved 30-day mortality. However, in 2012 a verysimilar trial, PROWESS-SHOCK [14], failed to show any signiﬁcant
mortality beneﬁt, and a 2012 Cochrane Review [15] similarly
showed no beneﬁt, prompting the removal of activated Protein C
(Xigris) from the market. However, purpura fulminans represents
the extreme of the pro-thrombotic spectrum of sepsis, and several
small case-series and case-control studies have suggested beneﬁt
of protein C administration in these patients [5,16–18]. For
instance, White et al. looked at 36 patients with purpura fulminans
given protein C concentrate (tradename Ceprotin) and saw
improvement compared to outcomes from other purpura ful-
minans patients not given protein C concentrate [5]. While
activated protein C is no longer available on the US market,
protein C concentrate (Ceprotin) still is and often is used in cases of
congenital purpura fulminans (from congenital protein C deﬁcien-
cy). Given the suggestion of beneﬁt in patients with sepsis-related
purpura fulminans, we attempted to give our patient protein C
concentrate but were not able to do so before she expired.
Rapid access to on-hand antimicrobials at the ﬁrst sign of fever,
a so called “pill-in-pocket” strategy, is an established part of care in
asplenic adult patients [2]. However, data supporting this
approach is sparse. While some studies have shown beneﬁt to
daily penicillin prophylaxis in asplenic children [19], this beneﬁt
seems to wane after 5 years of age [20], and antimicrobial
prophylaxis in adults is based on expert opinion [21]. Regardless, it
is recommended that febrile asplenic adults immediately take a
high-dose oral beta-lactam with encapsulated organism activity
such as amoxicillin-clavulanate 875 mg/125 mg, or extended-
spectrum ﬂuoroquinolone such as levoﬂoxacin 750 mg. Such
patients should then undergo prompt medical evaluation. In our
case, the patient had never been prescribed prophylactic anti-
microbials, though this intervention may have changed her
outcome. Unfortunately, this is a common occurrence among
asplenic patients [4]. Improving access for asplenic patients to
“pill-in-pocket” prophylactic antimicrobials, and increasing pro-
vider awareness, is necessary.
Streptococcus pneumoniae remains the most important cause of
morbidity and mortality in asplenic patients. Appropriate post-
splenectomy vaccinations and “pill-in-pocket” antimicrobials can
improve outcomes in this population. Purpura fulminans and
Waterhouse-Friderichsen syndrome represent life-threatening
complications for which optimal management is unclear.
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